However, the ERBB3 molecule demonstrates no kinase activity except when dimerised with EGFR or ERBB2, while ERBB2 expression is reported to be very low or absent in melanoma (Liu S. et al., 2021, Ueno et al., 2008; Inman et al., 2003). This evidence concerns the gene ERBB2 and melanoma.